Moderna MRNA United States — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Moderna’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's united states — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's united states — total revenue?
- Moderna (MRNA) reported united states — total revenue of $299.75M in Q4 2025.
- How has Moderna's united states — total revenue changed year-over-year?
- Moderna's united states — total revenue decreased by 32.8% year-over-year, from $446.25M to $299.75M.
- What is the long-term trend for Moderna's united states — total revenue?
- Over 4 years (2021 to 2025), Moderna's united states — total revenue has grown at a -33.6% compound annual growth rate (CAGR), from $6.18B to $1.2B.
- What does united states — total revenue mean?
- This metric represents the total gross income generated from the sale of goods and services within the United States geographic segment. It reflects the company's ability to monetize its product portfolio and capture market share within the domestic healthcare landscape. Fluctuations in this figure indicate changes in regional demand, pricing power, or the successful commercialization of new therapeutic candidates.